BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 31128236)

  • 1. NMR characterization of RNA small molecule interactions.
    Thompson RD; Baisden JT; Zhang Q
    Methods; 2019 Sep; 167():66-77. PubMed ID: 31128236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-observed NMR techniques to probe RNA-small molecule interactions.
    Calabrese DR; Connelly CM; Schneekloth JS
    Methods Enzymol; 2019; 623():131-149. PubMed ID: 31239044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-based investigations of RNA-small molecule interactions.
    McGovern-Gooch KR; Baird NJ
    Methods; 2019 Sep; 167():54-65. PubMed ID: 31129289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-ALIS: Methodology for screening soluble RNAs as small molecule targets using ALIS affinity-selection mass spectrometry.
    Rizvi NF; Nickbarg EB
    Methods; 2019 Sep; 167():28-38. PubMed ID: 31059829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space.
    Rizvi NF; Santa Maria JP; Nahvi A; Klappenbach J; Klein DJ; Curran PJ; Richards MP; Chamberlin C; Saradjian P; Burchard J; Aguilar R; Lee JT; Dandliker PJ; Smith GF; Kutchukian P; Nickbarg EB
    SLAS Discov; 2020 Apr; 25(4):384-396. PubMed ID: 31701793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using SHAPE-MaP to probe small molecule-RNA interactions.
    Martin S; Blankenship C; Rausch JW; Sztuba-Solinska J
    Methods; 2019 Sep; 167():105-116. PubMed ID: 31009771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frameworks for targeting RNA with small molecules.
    Umuhire Juru A; Hargrove AE
    J Biol Chem; 2021; 296():100191. PubMed ID: 33334887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery.
    Li Q; Kang C
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32605297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosensor-surface plasmon resonance: A strategy to help establish a new generation RNA-specific small molecules.
    Vo T; Paul A; Kumar A; Boykin DW; Wilson WD
    Methods; 2019 Sep; 167():15-27. PubMed ID: 31077819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery.
    Arntson KE; Pomerantz WC
    J Med Chem; 2016 Jun; 59(11):5158-71. PubMed ID: 26599421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule targeting of biologically relevant RNA tertiary and quaternary structures.
    Zafferani M; Hargrove AE
    Cell Chem Biol; 2021 May; 28(5):594-609. PubMed ID: 33823146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental free ligand conformations: a missing link in structure-based drug discovery.
    Chiarparin E; Packer MJ; Wilson DM
    Future Med Chem; 2019 Jan; 11(2):79-82. PubMed ID: 30648432
    [No Abstract]   [Full Text] [Related]  

  • 13. Counting on Fragment Based Drug Design Approach for Drug Discovery.
    Kashyap A; Singh PK; Silakari O
    Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Contributions of Conformational Changes, Thermodynamics, and Kinetics of RNA-Small Molecule Interactions.
    Umuhire Juru A; Patwardhan NN; Hargrove AE
    ACS Chem Biol; 2019 May; 14(5):824-838. PubMed ID: 31042354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent indicator displacement assays to identify and characterize small molecule interactions with RNA.
    Wicks SL; Hargrove AE
    Methods; 2019 Sep; 167():3-14. PubMed ID: 31051253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-targeted drug discovery: moving beyond promiscuous small-molecule scaffolds.
    L Garner A
    Future Med Chem; 2019 Oct; 11(19):2487-2490. PubMed ID: 31633403
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting RNA structures in diseases with small molecules.
    Shao Y; Zhang QC
    Essays Biochem; 2020 Dec; 64(6):955-966. PubMed ID: 33078198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule-RNA targeting: starting with the fundamentals.
    Hargrove AE
    Chem Commun (Camb); 2020 Nov; 56(94):14744-14756. PubMed ID: 33201954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.